Orgenesis Inc.

📍 Germantown, United States🗓 Founded 2012👥 66 employees💰 Last funded Jul 2021
Biotechnology🌐 orgenesis.com
Website LinkedIn
Orgenesis is a global biotech company that has been committed to unlocking the potential of decentralized cell and gene therapies (CGTs) since 2012. Orgenesis established the POCare Network in 2020 to bring academia, hospitals, and Industry together to make these innovations more affordable and accessible to patients. In 2022, the POCare Services business unit responsible for developing and managing the decentralized POCare Centers and proprietary OMPULs was formed. Orgenesis will continue to focus on advancing to market through various partnerships its CGTs to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2012
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Luxembourg
1
Belgium
1
Frequently asked questions
Who invested in Orgenesis Inc.?
Orgenesis Inc. has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Orgenesis Inc. last raise funding?
The most recent investment in Orgenesis Inc. recorded on gritt.io was in July 2021.
When was Orgenesis Inc. founded?
Orgenesis Inc. was founded in 2012.
What industry is Orgenesis Inc. in?
Orgenesis Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Orgenesis Inc. based?
Orgenesis Inc. is headquartered in Germantown, United States.